跳至主要内容
临床试验/KCT0001379
KCT0001379招募中未知

Efficacy and safety of gyejigachulbutang on patient with facet joint syndrome treated by posterior medial branch block - pilot study

Comprehensive and Integrative Medical Institute0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1. Facet joint syndrome patients, shows minimum 50% decrease of pain after posterior medial branch block as diagnotic purpose.
  • 2. Age 20 to 75 years.
  • 3. Ability to comprehend or express oneself in the Korean language
  • 4. Follow-up possible during the clinical trial
  • 5. Written informed consent voluntarily

排除标准

  • 1. All contraindications to corticosteroid injection (e.g., insulin-dependent diabetes)
  • 2. Senile dementia, impaired cognitive function or other cerebral disease, severe psychiatric or psychological disorders
  • 3. Alcohol/drug abuse
  • 4. Significant renal or hepatic disease
  • 5. Pregnant, lactating or planning a pregnancy
  • 6. suspected severe heart disease in ECG
  • 7. Refusal to participate in the trial or to provide informed consent
  • 8. An individual deemed to be ineligible by a physician

研究者

发起方
Comprehensive and Integrative Medical Institute

相似试验